Malaysian Genomics Resource Centre Bhd 2019 AR2
The report outlines the financial and operational performance of Malaysian Genomics Resource Centre Berhad (MGRC) for the fiscal year ended June 30, 2019. During the year, the company shifted its primary focus toward clinical pathology and genetic screening services, with pathology services contributing 98% of total revenue. MGRC expanded its pathology network to 20 laboratories, including new branches in Teluk Intan and Melaka. The company also expanded its genetic screening portfolio by introducing four new Dtect tests, bringing the total to 12. Additionally, MGRC published its inaugural sustainability statement, highlighting its commitment to high laboratory standards, environmental waste management, and community investment.
Company: Malaysian Genomics Resource Centre Bhd
Sector: Professional & technical services
Country: Malaysia
Year: 2019
Type: AR2
Pages: 128
Malaysian Genomics Resource Centre Bhd
The report outlines the financial and operational performance of Malaysian Genomics Resource Centre Berhad (MGRC) for the fiscal year ended June 30, 2019. During the year, the company shifted its primary focus toward clinical pathology and genetic screening services, with pathology services contributing 98% of total revenue. MGRC expanded its pathology network to 20 laboratories, including new branches in Teluk Intan and Melaka. The company also expanded its genetic screening portfolio by introducing four new Dtect tests, bringing the total to 12. Additionally, MGRC published its inaugural sustainability statement, highlighting its commitment to high laboratory standards, environmental waste management, and community investment.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Jul 1, 2018 - Jun 30, 2019
Fiscal Year
2019
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees